StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
NDRA

ENDRA Life Sciences Inc.

NDRA Nasdaq Electromedical & Electrotherapeutic Apparatus EDGAR ↗
$4.18
-0.15 -3.46%

Key statistics

from XBRL data in SEC filings
Market cap
$5.31M
Revenue (TTM)
$0.00
Net income (TTM)
-$7.30M
EPS (TTM)
$-8.93
P/E ratio
Dividend yield
Free cash flow
-$5.20M
Cash
$356K
Total assets
$3.44M
Gross margin
52-week range
$2.96 – $9.85

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 9, 2026 8-K Entered a material agreement; Change in control; Regulation FD disclosure; Other events Jun 26, 2026 8-K Regulation FD disclosure Jun 25, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events May 28, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Delisting notice or listing-rule failure Apr 21, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Exit or disposal costs; Regulation FD disclosure Mar 25, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Dec 15, 2025 8-K Director or officer change Nov 28, 2025 8-K Other events Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Entered a material agreement Oct 30, 2025 8-K Regulation FD disclosure; Other events Oct 23, 2025 8-K/A Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Item 5.08; Regulation FD disclosure; Other events Oct 15, 2025 8-K FORM 8-K Oct 15, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Other events Jul 23, 2025 8-K Results of operations (earnings release) Jul 9, 2025 8-K Regulation FD disclosure Jun 11, 2025 8-K Delisting notice or listing-rule failure May 30, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 31, 2025 8-K Regulation FD disclosure; Other events Nov 22, 2024 10-Q/A Quarter ended 2024-09-30 Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 19, 2024 8-K Results of operations (earnings release) Nov 15, 2024 8-K Modified rights of security holders; Amended charter or bylaws Nov 5, 2024 8-K Shareholder vote results; Other events Oct 29, 2024 8-K Regulation FD disclosure; Other events Aug 28, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 23, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Aug 16, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Director or officer change; Regulation FD disclosure Aug 13, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results; Other events Aug 9, 2024 8-K Delisting notice or listing-rule failure Jul 17, 2024